• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于抗癌治疗的自组装药物偶联物。

Self-assembly drug conjugates for anticancer treatment.

作者信息

Fumagalli Gaia, Marucci Cristina, Christodoulou Michael S, Stella Barbara, Dosio Franco, Passarella Daniele

机构信息

Dipartimento di Chimica, Università degli Studi di Milano, Via Golgi 19, 20133 Milano, Italy.

Dipartimento di Scienza e Tecnologia del Farmaco, Università degli Studi di Torino, Via Giuria 9, 10125 Torino, Italy.

出版信息

Drug Discov Today. 2016 Aug;21(8):1321-9. doi: 10.1016/j.drudis.2016.06.018. Epub 2016 Jun 18.

DOI:10.1016/j.drudis.2016.06.018
PMID:27329268
Abstract

Self-assembly drug conjugate preparation is a promising approach to improve activity and penetration through physiological barriers of potent small molecules, as well as to reduce any side effects. Drug conjugates can self-assemble in water to form nanoparticles (NPs) that offer several advantages because: (i) they are easy to obtain; (ii) they can reach high local drug concentration in tumor tissues; and (iii) they can reduce the side effects of drugs. All these factors improve drug pharmacokinetic properties. Here, we have reviewed the scope of nanotechnology-based self-assembly drug delivery approaches focusing on prodrugs able to form NPs by self-assembly; we have also summarized the current perspective and challenges facing the successful treatment of cancer.

摘要

自组装药物缀合物的制备是一种很有前景的方法,可提高强效小分子的活性并穿透生理屏障,同时减少任何副作用。药物缀合物可在水中自组装形成纳米颗粒(NPs),具有以下几个优点:(i)易于制备;(ii)可在肿瘤组织中达到高局部药物浓度;(iii)可减少药物的副作用。所有这些因素都改善了药物的药代动力学性质。在此,我们综述了基于纳米技术的自组装药物递送方法的范围,重点关注能够通过自组装形成纳米颗粒的前药;我们还总结了当前癌症成功治疗面临的前景和挑战。

相似文献

1
Self-assembly drug conjugates for anticancer treatment.用于抗癌治疗的自组装药物偶联物。
Drug Discov Today. 2016 Aug;21(8):1321-9. doi: 10.1016/j.drudis.2016.06.018. Epub 2016 Jun 18.
2
Prodrug-based nanoparticulate drug delivery strategies for cancer therapy.基于前药的纳米颗粒药物传递策略用于癌症治疗。
Trends Pharmacol Sci. 2014 Nov;35(11):556-66. doi: 10.1016/j.tips.2014.09.008. Epub 2014 Oct 16.
3
Prodrugs in combination with nanocarriers as a strategy for promoting antitumoral efficiency.前药与纳米载体联合作为提高抗肿瘤效率的策略。
Future Med Chem. 2019 Aug;11(16):2131-2150. doi: 10.4155/fmc-2018-0388.
4
Recent Approaches to Platinum(IV) Prodrugs: A Variety of Strategies for Enhanced Delivery and Efficacy.铂(IV)前药的最新研究方法:多种增强递送和疗效的策略
Curr Pharm Des. 2017;23(16):2366-2376. doi: 10.2174/1381612823666170201161037.
5
Heparin-paclitaxel conjugates as drug delivery system: synthesis, self-assembly property, drug release, and antitumor activity.肝素-紫杉醇偶联物作为药物传递系统:合成、自组装特性、药物释放和抗肿瘤活性。
Bioconjug Chem. 2009 Dec;20(12):2214-21. doi: 10.1021/bc8003809.
6
Nanotechnology-based combinational drug delivery: an emerging approach for cancer therapy.基于纳米技术的联合药物递送:癌症治疗的一种新兴方法。
Drug Discov Today. 2012 Sep;17(17-18):1044-52. doi: 10.1016/j.drudis.2012.05.010. Epub 2012 May 29.
7
Block copolymer prodrugs: Synthesis, self-assembly, and applications for cancer therapy.嵌段共聚物前药:合成、自组装及其在癌症治疗中的应用。
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2020 Jan;12(1):e1585. doi: 10.1002/wnan.1585. Epub 2019 Aug 26.
8
Tumor targeting: activation of prodrugs by enzyme-monoclonal antibody conjugates.肿瘤靶向:酶-单克隆抗体偶联物对前药的激活作用。
Trends Biotechnol. 1994 Jun;12(6):234-9. doi: 10.1016/0167-7799(94)90122-8.
9
Nanoparticles as delivery carriers for anticancer prodrugs.纳米粒作为抗癌前药的递送载体。
Expert Opin Drug Deliv. 2012 Jun;9(6):657-69. doi: 10.1517/17425247.2012.679927. Epub 2012 Apr 16.
10
Combination of small molecule prodrug and nanodrug delivery: amphiphilic drug-drug conjugate for cancer therapy.小分子前药与纳米药物递送的结合:用于癌症治疗的两亲性药物-药物偶联物。
J Am Chem Soc. 2014 Aug 20;136(33):11748-56. doi: 10.1021/ja505212y. Epub 2014 Aug 7.

引用本文的文献

1
Self-Assembled Cannabigerol-Based Nanoparticles: Design, Synthesis, and Antiproliferative Activity.基于大麻二酚的自组装纳米颗粒:设计、合成及抗增殖活性
Pharmaceutics. 2025 May 11;17(5):636. doi: 10.3390/pharmaceutics17050636.
2
Ecdysteroid-Containing Squalenoylated Self-Assembling Nanoparticles Exert Tumor-Selective Sensitization to Reactive Oxygen Species (ROS)-Induced Oxidative Damage While Protecting Normal Cells: Implications for Selective Radiotherapy.含蜕皮甾类的角鲨烯化自组装纳米颗粒对活性氧(ROS)诱导的氧化损伤具有肿瘤选择性增敏作用,同时保护正常细胞:对选择性放射治疗的启示
J Med Chem. 2025 Apr 10;68(7):7197-7212. doi: 10.1021/acs.jmedchem.4c02758. Epub 2025 Mar 28.
3
How Advanced are Self-Assembled Nanomaterials for Targeted Drug Delivery? A Comprehensive Review of the Literature.
用于靶向药物递送的自组装纳米材料有多先进?文献综述
Int J Nanomedicine. 2025 Feb 19;20:2133-2161. doi: 10.2147/IJN.S490444. eCollection 2025.
4
Overcoming challenges in the delivery of STING agonists for cancer immunotherapy: A comprehensive review of strategies and future perspectives.克服癌症免疫治疗中STING激动剂递送的挑战:策略与未来展望的全面综述
Mater Today Bio. 2023 Oct 21;23:100839. doi: 10.1016/j.mtbio.2023.100839. eCollection 2023 Dec.
5
Engineering of Amphiphilic Erlotinib Analogue as Novel Nanomedicine for Non-Small Cell Lung Cancer Therapy.两亲性埃罗替尼类似物的工程设计作为治疗非小细胞肺癌的新型纳米药物。
Int J Nanomedicine. 2023 Nov 7;18:6367-6377. doi: 10.2147/IJN.S432464. eCollection 2023.
6
2-Hydroxyoleic Acid as a Self-Assembly Inducer for Anti-Cancer Drug-Centered Nanoparticles.2-羟基油酸作为以抗癌药物为核心的纳米颗粒的自组装诱导剂
Pharmaceuticals (Basel). 2023 May 9;16(5):722. doi: 10.3390/ph16050722.
7
Cannabidiol as Self-Assembly Inducer for Anticancer Drug-Based Nanoparticles.基于抗癌药物的纳米粒子的自组装诱导剂——大麻二酚。
Molecules. 2022 Dec 23;28(1):112. doi: 10.3390/molecules28010112.
8
Dehydroroyleanone as a Building Block for a Drug Delivery Platform Based on Self-Assembled Nanoparticles: Structural Studies and Chemical Modification.去氢罗勒烯酮作为基于自组装纳米颗粒的药物递送平台的构建模块:结构研究与化学修饰
ACS Omega. 2022 Nov 23;7(48):44180-44186. doi: 10.1021/acsomega.2c05353. eCollection 2022 Dec 6.
9
Research Progress of Carrier-Free Antitumor Nanoparticles Based on Phytochemicals.基于植物化学物质的无载体抗肿瘤纳米颗粒的研究进展
Front Bioeng Biotechnol. 2021 Dec 8;9:799806. doi: 10.3389/fbioe.2021.799806. eCollection 2021.
10
A Carrier-Free Folate Receptor-Targeted Ursolic Acid/Methotrexate Nanodelivery System for Synergetic Anticancer Therapy.一种无载体的叶酸受体靶向熊果酸/甲氨蝶呤纳米递药系统用于协同抗癌治疗。
Int J Nanomedicine. 2021 Mar 3;16:1775-1787. doi: 10.2147/IJN.S287806. eCollection 2021.